Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina: Adenosine in the perfused eye

Documenta Ophthalmologica

Volumn 106, Issue 1, 2003, Pages 51-59

  Macaluso, Claudio ^a   Frishman, Laura J ^b   Frueh, Beatrice ^c   Kaelin Lang, Alain ^c   Onoe, Shoken ^d   Niemeyer, Günter ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF HOUSTON   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d Department of Ophthalmology ^*  (Japan)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adenosine; Isolated perfused cat eye; Neuroprotection; Optic nerve; Retina; Retinal ganglion cells

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE INHIBITOR; DIPYRIDAMOLE;

ANIMAL TISSUE; ARTERY PERFUSION; CAT; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EYE; GLYCOGENOLYSIS; HYPOXIA; ISCHEMIA; ISOLATED ORGAN; METABOLIC INHIBITION; NERVE CONDUCTION; NERVE STIMULATION; NEUROPROTECTION; NEUTROPHIL; NIGHT VISION; NONHUMAN; OPTIC NERVE; RETINA; THROMBOCYTE AGGREGATION; VASODILATATION;

ADENOSINE; ANIMALS; CATS; CILIARY ARTERIES; ELECTRORETINOGRAPHY; NEUROPROTECTIVE AGENTS; OPHTHALMIC ARTERY; OPTIC NERVE; PERFUSION; RETINA; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0037235610     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022456615715     Document Type: Conference Paper

References (58)

1. Blazynski C, Cohen AI, Frueh B, Niemeyer G. Adenosine: Autoradiographic localization and electrophysiologic effects in cat retina. Invest Ophthalmol Vis Sci 1989; 30: 2533-6.
2. Frueh B, Niemeyer G, Onoe S. Adenosine enhances the ERG b-wave and depresses the light peak in perfused cat eyes. ARVO Abstracts. Invest Ophthalmol Vis Sci ARVO Abstracts. 1989; 30(Suppl): 124.
3. Niemeyer G, Früh B. Adenosine inhibits the optic nerve response in the perfused cat eye. ARVO Abstracts. ARVO Abstracts. Invest Ophthalmol Vis Sci 1989; 30(Suppl): 124.
4. Niemeyer G, Frueh B. Adenosine and cyclohexyladenosine inhibit the cat's optic nerve action potential. Experientia 1989; 45: 18(Abstract).
5. Niemeyer G, Frishman LJ, Macaluso C. Adenosine inhibits maintained and light-evoked activity in X- and Y- ganglion cells in the perfused cat eye. Invest Ophthalmol Vis Sci (Suppl) 1991; 32: 1265 (Abstract).
6. Macaluso C, Onoe S, Niemeyer G. STR and optic nerve response in vitro share adenosine-induced inhibition and changes parallel with glucose level. Invest Ophthalmol Vis Sci 1992; 33; 1033.
7. Kaelin-Lang A, Jurklies B, Niemeyer G. Effects of an adenosine A2-agonist and -antagonist on cat retina in vitro. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995; 36: S449.
8. Kaelin-Lang A, Jurklies B, Niemeyer G. Effects of adenosinergic agents on the vascular resistance and on the optic nerve response in the perfused cat eye. Vision Res 1999; 39: 1059-68.
9. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptor. Pharmacol Rev 1994; 46: 143-56.
10. Nyce JW. Insight into adenosine receptor function using antisense and gene-knockout approaches. Trends Pharmacol Sci 1999; 20: 79-83.
11. Dragunow M, Faull RLM. Neuroprotective effects of adenosine. Trends Pharmacol Sci 1988; 9: 193.
12. Rudolphi K, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 1992; 13: 439-45.
13. Deckert J, Gleiter CH. Adenosine - An endogenous neuroprotective metabolite and neuromodulator. J Neural Transm 1994; 43: 23-31.
14. Phillis JW. Adenosine agonists and antagonists. In: Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B, eds., Primer on Cerebrovascular Disease. San Diego, CA: Academic Press, 1997; 230-53.
15. Von Lubitz DJKE. Adenosine and acute treatment of cerebral ischemia and stroke - 'Put out more flags'. In: Jacobson KA, Jarvis MF, eds., Purinergic Approaches in Experimental Therapeutics. New York, Wiley-Liss 1997; 449-70.
16. Larsen AK, Osborne NN. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci 1996; 37: 2603-11.
17. Phillis JW Adenosine in the control of the cerebral circulation. Cerebrovasc Brain Metab Rev 1989; 1: 26-54.
18. Ibayashi S, Ngai AC, Meno JR, Winn HR. Effects of topical adenosine analogs and forskoline on rat pial arterioles in vivo. J Cereb Blood Flow Metab 1991; 11: 72-6.
19. Magistretti PJ, Hof PR, Martin JL. Adenosine stimulates glycogenolysis in mouse cerebral cortex: A possible coupling mechanism between neuronal activity and energy metabolism. J Neurosci 1986; 6: 2558-62.
20. 2+-dependent glycogen hydrolysis in mouse cerebral cortex. J Neurosci 1988; 8: 1922-8.
21. 3H]Glycogen hydrolysis elicited by adenosine in rabbit retina: Involvement of A2-receptors. Neurochem Int 1989; 14: 419-22.
22. Ledent C, Vangeois JM, Sciffman SN, Pedrazzini T, Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388: 674-8.
23. Sandoli D, Chiu PJS, Chintala M, Dionisotti S, Ongini E. In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit. Eur J Pharmacol 1994; 259: 43-9.
24. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76: 5-13.
25. Jordan JE, Zhao ZQ, Sato H, Taft S, Vinten-Johansen J. Adenosine A2-receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 1997; 280-301-9.
26. Niemeyer G. Neurobiology of perfused mammalian eyes. J Neurosci Methods 1981; 3: 317-37.
27. Niemeyer G. Retinal research using the perfused mammalian eye. Prog Retinal Eye Res 2001; 20:289-318.
28. Enroth-Cugell C, Robson JG. The contrast sensitivity of retinal ganglion cells of the cat. J Physiol 1966; 187: 517-52.
29. Braas KM, Zarbin MA, Snyder SH. Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina. Proc Natl Acad Sci USA 1987; 84: 3906-10.
30. Blazinski C. Discrete distributions of adenosine receptors in mammalian retina. J Neurochem 1990; 54: 648-55.
31. Blazynski C, Perez MTR. Adenosine in vertebrate retina: Localization, receptor characterization and function. Cell Mol Neurobiol 1991; 11: 463-84.
32. Borisy FF, Hwang PN, Ronnett GV, Snyder SH. High-affinity cAMP phosphodiesterase and adenosine localized in sensory organs. Brain Res 1993; 610: 199-207.
33. Crosson CG, DeBenedetto R, Gidday JM. Functional evidence for retinal adenosine receptors. J Ocular Pharmacol 1994; 10: 499-507.
34. Paes De Carvalho R, Braas K, Snyder SH, Adler R. Analysis of adenosine immunoreactivity, uptake and release in purified cultures of developing chick embryo retinal neurons and photoreceptors. J Neurochem 1990; 55: 1603-11.
35. Portellos M, Riva CE, Cranstoun SD, Petrig BL, Brucker AJ. Effects of adenosine on ocular blood flow. Invest Ophthalmol Vis Sci 1995; 36: 1904-9.
36. Ostwald P, Park SS, Toledano AY, Roth S. Adenosine receptor blockade and nitric oxide synthase inhibition in the retina: Impact upon post-ischemic hyperemia and the electroretinogram. Vision Res 1997; 37: 3453-61.
37. Drury AN, Szent-Gyoergyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929; 68: 213-37.
38. Braunagel SC, Xiao JG, Chiou GCY. The potential role of adenosine in regulating blood flow in the eye. J Ocul Pharmacol 1988; 4: 61-73.
39. Campochiaro PA, Sen HA. Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies. Arch Ophthalmol 1989; 107: 412-6.
40. Gidday JM, Park TS. Microcirculatory responses to adenosine in the newborn pig retina. Pediatr Res 1993; 33: 620-7.
41. Li B, Yang C, Rosenbaum DM, Roth S. Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp Eye Res 2000; 70: 755-65.
42. Berne RM, Rubio R, Curnish RR, Release of adenosine from ischemic brain. Effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res 35: 1974; 262-71.
43. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Scwarzschild MA. A2a adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 1999; 19: 9192-200.
44. Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E. Blockade of A2a adenosine receptors by SCH 58261 results in neuroprotective effects in cerebral ischemia in rats. NeuroReport 1998; 9: 3955-9.
45. Sieving PA, Frishman LJ, Steinberg RH. Scotopic threshold response of proximal retina in the cat. J Neurophysiol 1986; 56: 1049-61.
46. Frishman L. The scotopic threshold response. In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision. St Louis, MO: Mosby-Year Book, 1991.
47. Niemeyer G, Kleinert D. Scotopic threshold responses and optic nerve action potential of the perfused cat eye share important features. Invest Ophthalmol Vis Sci (Suppl) 2001; 42: 179 (Abstract).
48. Mager R, Ferroni S, Schubert P. Adenosine modulates a voltage-dependent chloride conductance in cultured hippocampal neurons. Brain Res 1990; 532: 58-62.
49. Hossmann KA. Glutamate-mediated injury in focal cerebral ischemia: The excitoxin hypothesis revised. Brain Pathol 1994; 4: 23-36.
50. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res 1991; 53: 573-82.
51. Osborne NN, Herrera AJ. The effect of experimental ischemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina. Neuroscience 1994; 59: 1071-81.
52. Peng YW, Blackstone CD, Huganir RL, Yau KW. Distribution of glutamate receptor subtypes in the vertebrate retina. Neuroscience 1995; 60: 483-97.
53. Granit R. The components of the retinal action potential and their relation to the discharge in the optic nerve. J Physiol 1933; 77: 207.
54. Macaluso C, Onoe S, Niemeyer G. Changes in glucose level affect rod function more than cone function in the isolated, perfused cat eye. Invest Ophthalmol Vis Sci 1992; 33: 2798-808.
55. Rungger-Brändle E, Kolb H, Niemeyer G. Histochemical demonstration of glycogen in neurons of the cat retina. Invest Ophthalmol Vis Sci 1996; 37: 702-15.
56. Newman EA, Frishman LJ. The b-wave. In: Heckenlively JR, Arden GB (eds). Principles and Practice of Clinical Electrophysiology of Vision. St. Louis, MO: Mosby Year Book 1991: 101-11.
57. Masland RH, Ames A III. Dissociation of field potential from neuronal activity in the isolated retina: Failure of the b-wave with normal ganglion cell response. J Neurobiol 1975; 6: 305-12.
58. Snyder SH. Knockouts anxious for new therapy. Nature 1997; 388: 624.